CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models

Vijil Chenthamarakshan, Payel Das, Samuel C. Hoffman +8

The novel nature of SARS-CoV-2 calls for the development of efficient de novo drug design approaches. In this study, we propose an end-to-end framework, named CogMol (Controlled Ge…